Publications by authors named "Jason Slakter"

Claim this Profile
S
Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis.
Chui Ming Gemmy Cheung, Timothy L Jackson, Charles C Wykoff, Arshad M Khanani, Ian M Leitch, Jason Slakter

Ophthalmol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Jason S Slakter

Immunotherapy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sozinibercept Combination Therapy for Neovascular Age-related Macular Degeneration: Phase 2b Study Subgroup Analysis by Lesion Type.
Charles C Wykoff, Timothy L Jackson, Clare F Price, Megan E Baldwin, Ian M Leitch, Jason Slakter

Ophthalmic Surg Lasers Imaging Retina· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, Jason S Slakter

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Timothy L Jackson, Jason Slakter, Marc Buyse, Kun Wang, Pravin U Dugel

Ophthalmology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Charles C Wykoff, Philip J Rosenfeld, Nadia K Waheed, Rishi P Singh, Nick Ronca, Jason S Slakter

Ophthalmology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
Jeffrey S Heier, Allen C Ho, Michael A Samuel, Tom Chang, Christopher D Riemann, Jason S Slakter

Ophthalmol Retina· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
David S Liao, Federico V Grossi, Delphine El Mehdi, Monica R Gerber, David M Brown, Jason S Slakter

Ophthalmology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
Jessica Ackert, Khadeeja Mohamed, Jason S Slakter, Sherif El-Harazi, Alessandro Berni

Drug Saf· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial.
Florentina Joyce Freiberg, Stephan Michels, Alyson Muldrew, Jason Slakter, Denis O'Shaughnessy

Br J Ophthalmol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies.
Paolo Lanzetta, Alan F Cruess, Salomon Y Cohen, Jason S Slakter, Todd Katz

Acta Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.
Jasmine H Francis, Jason S Slakter, David H Abramson, Steven A Odrich, Y Pierre Gobin

Am J Ophthalmol Case Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FULL-THICKNESS MACULAR HOLE COMBINED WITH PIGMENT EPITHELIAL DETACHMENT USING MULTIMODAL IMAGING.
Maiko Inoue, Anna Tan, Jason S Slakter, Stanley Chang, Kazuaki Kadonosono

Retin Cases Brief Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study.
Timothy L Jackson, David Boyer, David M Brown, Nauman Chaudhry, Michael Elman, Jason S Slakter

JAMA Ophthalmol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy.
Anna C S Tan, Polina Astroz, Kunal K Dansingani, Jason S Slakter, Lawrence A Yannuzzi

Invest Ophthalmol Vis Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.
Sebastian Wolf, Francesco Bandello, Anat Loewenstein, Jason Slakter, Todd Katz

Ophthalmologica· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Jason S Slakter

Ophthalmology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Algorithmic Diabetic Retinopathy Severity Scoring System (An American Ophthalmological Society Thesis).
Jason S Slakter, Jeffrey W Schneebaum, Sabah A Shah

Trans Am Ophthalmol Soc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Jason S Slakter

Ophthalmology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study.
Ugo Introini, Giuseppe Casalino, Giacinto Triolo, Denis O'Shaughnessy, E Mark Shusterman, Jason S Slakter

Ophthalmologica· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study.
Timothy L Jackson, Usha Chakravarthy, Jason S Slakter, Alyson Muldrew, E Mark Shusterman

Ophthalmology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jason S Slakter

Ophthalmology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments.
Irene M Rusu, Avnish Deobhakta, Dan Yoon, Michele Lee, Jason S Slakter

Retina· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.
Carl Schubert, Anders Pryds, Shemin Zeng, Yajing Xie, K Bailey Freund, Jason S Slakter

Hum Mutat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration.
Megan M McLaughlin, Marcella G Paglione, Jason Slakter, Michael Tolentino, Li Ye

JAMA Ophthalmol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis